Psychedelic drugs can induce mind-altering states affecting perception, thought and sensory input.
They have historically been known for their recreational use and do not have nationwide legal approval.
However, psychedelic drugs are also increasingly being studied for their medical benefits (particularly with regard to mental health).
Learn more below about how certain psychedelics can—and cannot—be used for mental wellness.
Read more
So much information here!
The NIH Workshop on Psychedelics as Therapeutics was conducted by the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Alcohol Abuse and Alcoholism.
Read more
This study looks at four scientific articles on microdosing. Three of these indicate potential benefits from microdosing.
Read more
BBC Future profiles MAPS Founder Rick Doblin, Ph.D., in an extensive article exploring the international impact of psychedelics on science, drug policy, culture, and medicine.
By highlighting the rapid increase in psychedelic research over the past ten years, Ed Prideaux of BBC explains how clinical trial results, favorable media coverage, and the potential development of new mental health treatments are steadily moving the public perception of psychedelics toward mainstream acceptance.
"Now the efforts of Doblin and others are finally paying off,” writes Prideaux. "Promising clinical trials suggest that psychedelics may prove game-changing treatments for depression, PTSD and addiction."
Read more
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary.
Read more